Patent ID: 8338111

Claim:
A method of diagnosing the absence of endometriosis in a subject considered to be at high risk of having endometriosis, the method comprising the steps of: a. Obtaining a biological sample from the subject; b. Determining the amount of CA-125, macrophage chemoattractant protein-1 (MCP-1) and Leptin in said biological sample of the subject; and, c. Comparing the amount of said CA-125, macrophage chemoattractant protein-1 (MCP-1) and Leptin to a reference standard, whereby if the amount determined for CA-125, Leptin, and macrophage chemoattractant protein-1 (MCP-1) are less than about 20.0 mIU/mL, 14 ng/mL, and 152.7 pg/mL, the subject does not have endometriosis.